Narittira Ornnork
Name: Narittira Ornnork
Office address: B704A, 7th Floor, Biomedical Science Building 54 Kamphaeng Phet 6 Talat Bang Khen, Lak Si, Bangkok 10210, Thailand
Tel: +66 2553 8555 (ext. 8349)
Mobile: 0982716213
E-mail: [email protected]
Research Assistant
Research Interests
Cancer biology, Cell signaling, Drug resistance, Drug discovery, Apoptosis
Education
– B.Sc. (Biotechnology), King Mongkut’s University of Technology North Bangkok, THAILAND
Publications
1. Ornnork, N., Kiriwan, D., Lirdprapamongkol, K., Choowongkomon, K., Svasti, J., & Eurtivong, C. (2020). Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Journal of Molecular Graphics and Modelling, 99, 107639.
2. Saruengkhanphasit, R., Butkinaree, C., Ornnork, N., Lirdprapamongkol, K., Niwetmarin, W., Svasti, J., & Eurtivong, C. (2021). Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure–activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study. Bioorganic Chemistry, 110, 104795.
3. Keeratichamroen, S., Lirdprapamongkol, K., Thongnest, S., Boonsombat, J., Chawengrum, P., Sornprachum, Ornnork, N., & Svasti, J. (2022). JAK2/STAT3‑mediated dose‑dependent cytostatic and cytotoxic effects of sesquiterpene lactones from Gymnanthemum extensum on A549 human lung carcinoma cells. Oncology Reports, 47(1), 1-11.
